metaPreg - Opipramol during pregnancy

Opipramol updated on 10-20-2025

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	23.10 [0.79, 671.66]	-	1 study	3	2	not evaluable	ROB	-
Major congenital malformations	23.10 [0.79, 671.66]	-	1 study	3	2	not evaluable	ROB	-
Growth parameters and prematurity
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Preterm (< 37 weeks)	9.31 [0.35, 245.79]	-	1 study	8	2	not evaluable	ROB	-
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Early intrauterine deaths (< 22 weeks) / Spontaneous abortions	2.81 [0.32, 24.74]	0%	2 studies	24	10	not evaluable	ROB	-
Elective/induced termination of pregnancy	5.99 [0.23, 153.53]	-	1 study	14	2	not evaluable	ROB	-
Hide endpoints reported in only one study ...